The Patent Finder
TP

Tonix Pharmaceuticals Holding Corp.

First filing 2008
OverviewNotableFeesChangesFamiliesPatent listSources & methods

3 patents currently held

28 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jul 2038. from the record

Of the 28 now held by other companies, 14 were conveyed to Tonix Pharma Holdings Limited in the filing they arrived in, and 14 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jul 2038
Next term end
2
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 40 later US patents, top 10% of utility patents granted in 2018 in our data. Protection runs to 2034.
Ends Mar 2034 · High confidence
Also notable
Cited by 6 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2035. A terminal disclaimer caps this term to an earlier patent's.
Ends Sep 2035 · High confidence
Also notable
Cited by 29 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Ends Jun 2031 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 17, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 3 of 3

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 11,517,557Analogs of Cyclobenzaprine and Amitryptilene
In force
 · High confidence
In forceHigh confidence
US 12,156,864Analogs of Cyclobenzaprine and Amitryptilene
In force
 · High confidence
In forceHigh confidence
US 11,566,032Radio-Protective and Chemo-Protective Substituted Thiols
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 3: 28 patents in force now held by others · 2 patents ended · 18 applications pending · 16 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited